NKX2-5 and coronary artery disorder: We previously took an epigenomics approach to understanding CHD mechanism, profiling the genomic targets of NKX2-5 WT and a single natural disease-causing variant, Y191C128, as well as two synthetic mutations, one lacking the entire homeodomain (ΔHD)33.